BioRender 아이콘

Ciliated epithelial cell 1

Ciliated epithelial cell 1 - Editable icon of Pseudostratified columnar epithelium with ciliated cells
[{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb06/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb06/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb07/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb07/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb08/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb08/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb09/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb09/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb0a/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb0a/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb0b/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb0b/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb0c/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb0c/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb0d/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb0d/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb0e/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb0e/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb0f/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb0f/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb10/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb10/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb11/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb11/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb12/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb12/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb13/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb13/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb14/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb14/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb15/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb15/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb16/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb16/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb17/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb17/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb18/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb18/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb19/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb19/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb1a/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb1a/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb1b/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb1b/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb1c/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb1c/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb1d/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb1d/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb1e/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb1e/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb1f/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb1f/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb20/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb20/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb21/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb21/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb22/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb22/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb23/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb23/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb24/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb24/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb25/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb25/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb26/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb26/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb27/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb27/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb28/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb28/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb29/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb29/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb2a/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb2a/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb2b/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb2b/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb2c/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb2c/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb2d/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb2d/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb2e/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb2e/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb2f/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb2f/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb30/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb30/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb31/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb31/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb32/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb32/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb33/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb33/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb34/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb34/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb35/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb35/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb36/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb36/5c0ad6a7c806e41200cdffe8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df4773ed9462577e08bb37/5c0ad6a7c806e41200cdffe8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df4773ed9462577e08bb37/5c0ad6a7c806e41200cdffe8.png"}]
이 아이콘 사용하기 – 무료
가입 시 신용카드가 필요하지 않습니다.

이 아이콘은 BioRender에서 자유롭게 편집할 수 있습니다

  • 텍스트, 도형 및 기타 아이콘 추가
  • 5만 개 이상의 과학적으로 정확한 아이콘을 검색하세요
  • 모든 아이콘, 선, 라벨의 색상과 배치를 자유롭게 변경하세요
  • 어떤 용도로든 내보내거나 공유하세요
Scientist Avatars

이미 출판용 수준의 그림을 만들고 있는 400만 명 이상의 과학자들과 함께하세요

아이콘으로 몇 분 만에 완성된 그림을 만들어 보세요

  • 검색 50,000개 이상의 과학적으로 정확하고 동료 검토를 거친 아이콘 제공
  • 맞춤 설정 라벨, 도형, 추가 아이콘을 사용하여 모든 요소를 자유롭게 편집할 수 있습니다.
  • 내보내기 또는 공동 작업자와 그림 공유하기
    ‍

찾으시는 아이콘이 아닌가요? 더 많은 아이콘을 확인해 보세요.

30개 이상의 생명과학 분야에 걸친 50,000개 이상의 아이콘을 검색하세요.

search icon
arrow-right
epithelium,columnar,epithelia,cilia,ciliated,pseudostratified epithelium,pseudostratified epithelial cell ciliated
더 보기

동의어를 검색하거나 가입하여 앱에서 아이콘을 요청해 보세요.

이미지 유형

Ciliated epithelial cell 1 icon JPEG

Ciliated epithelial cell 1 icon PNG

Ciliated epithelial cell 1 icon SVG

Ciliated epithelial cell 1 icon GIF

BioRender 아이콘 FAQ

How are scientists using the Ciliated epithelial cell 1 icon in their work?

BioRender users often use the Ciliated epithelial cell 1 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

이 아이콘을 BioRender 그림이나 과학 일러스트레이션에 사용할 수 있나요?

Yes, the Ciliated epithelial cell 1 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Ciliated epithelial cell 1 icon customizable in BioRender?

Most icons in BioRender, including the Ciliated epithelial cell 1 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Ciliated epithelial cell 1 icon for publication or presentations?

Yes, figures containing the Ciliated epithelial cell 1 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Ciliated epithelial cell 1 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Ciliated epithelial cell 1 icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

BioRender란 무엇인가요?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Ciliated epithelial cell 1 icon along with our library of more than 30,000 life science icons.

BioRender에서 이 아이콘 사용하기

지금 바로 전문가 수준의 과학 피규어를 만들어 보세요
antibody elements3D Phospholipid illustration

과학 콘텐츠를 찾고 계신가요?

동료 검토를 거쳐 사용하기 쉽고 무료로 제공되는 5만 개 이상의 아이콘과 템플릿을 살펴보세요.

지금 바로 찾아보세요
x icon